Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

AstraZeneca has unveiled a double dose of approvals awarded to its medicines in Japan: Fasenra in asthma, and Lynparzain ovarian cancer.
Rumours of a $7billion Juno Therapeutics takeover by Celgene, accelerated approval in the US and Europe for Novartis' CAR T therapy Kymriah, and...
Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and has made another move to further...
UK regulator NICE has announced its decision not to recommend Pfizer’s Xalkori (crizotinib) for use on the NHS in the treatment of ROS1-positive...

Features

As industry discourse continues to discuss how real world evidence can be transformative for the regulatory landscape, Jacqueline Corrigan-Curay...

Appointments

GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific,...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches